Abstract
Objective To assess a dose-response effect of methylphenidate use on restorative treatment needs, which served as an indicator of caries.
Subjects and Methods This study is a retrospective cohort of military recruits aged 18-25 who served for 12 to 48 months between 2005 and 2017. The cohort included 6,875 subjects with ADHD who received treatment with methylphenidate, 6,729 subjects with ADHD who had no prescriptions for methylphenidate, and 200,000 healthy controls. The outcome was normative treatment needs: having at least one recommendation for restorative treatment during the study period.
Results Frequency of recommendation for restorative treatment among the treated, the untreated and the control groups was 24%, 22% and 17%, respectively (p<0.0001). On multivariate analysis, the dose-response association between methylphenidate use and the odds of having at least one restorative treatment was confirmed (OR=1.006 for each additional 1 gr of methylphenidate; 95% CI [1.004:1.009]).
Conclusions Subjects with ADHD who receive chronic treatment with methylphenidate have higher restorative treatment needs than subjects with untreated ADHD and healthy controls. Our results show that chronic methylphenidate medication among young adults leads to an elevated need for restorative treatment and implies a significant impact on oral health.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of the Israel Defense Forces Medical Corps, Tel Hashomer, Israel
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos